Centre Hospitalier de Jolimont

Haine-Saint-Paul 7100

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Castration-Resistant Prostate Cancer (mCRPC), Squamous Cell Carcinoma of the Head and Neck

Studies at this site

• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer — Running, not enrolling
• Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100) — Stopped early